Abbott Medical Devices Trading (Shanghai) Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Device: Transthoracic Impedance

First Posted Date: 2007-07-13

Last Posted Date: 2019-02-01

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 75

Registration Number: NCT00500838

Locations: 🇺🇸
Baptist Health Medical Center, Little Rock, Arkansas, United States
🇺🇸
Deborah Heart and Lung, Browns Mills, New Jersey, United States
🇺🇸
Glendale Memorial Hospital, Glendale, California, United States

and more 1 locations

XIENCE V: SPIRIT WOMEN

Phase 4

Completed

Conditions: Coronary Artery Stenosis
Coronary Artery Restenosis
Vascular Disease
Total Coronary Occlusion
Coronary Arteriosclerosis
Coronary Artery Disease
Myocardial Ischemia
Stent Thrombosis

Interventions: Device: XIENCE V®/ XIENCE PRIME™

First Posted Date: 2007-07-06

Last Posted Date: 2015-05-13

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1600

Registration Number: NCT00496938

Locations: 🇳🇱
AMC, Amsterdam, Netherlands
🇮🇹
Azienda Ospedaliera Santa Maria Nuova, Reggio Emilia, Italy
🇮🇹
Centro Cardiologico Monzino, Milan, Italy

and more 91 locations

The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis

Not Applicable

Completed

Conditions: Renal Artery Obstruction
Hypertension, Renal

Interventions: Device: Herculink Elite Renal Stent System

First Posted Date: 2007-06-25

Last Posted Date: 2012-12-18

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 202

Registration Number: NCT00490841

Locations: 🇺🇸
Abbott Vascular, Santa Clara, California, United States

DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation

Not Applicable

Terminated

Conditions: Coronary Artery Disease
Left Ventricular Dysfunction
Sudden Cardiac Death

Interventions: Device: Defibrillator
Other: Control

First Posted Date: 2007-06-18

Last Posted Date: 2019-02-05

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 81

Registration Number: NCT00487279

Locations: 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸
New York Methodist Hospital, Brooklyn, New York, United States
🇺🇸
Hoag Memorial Hospital Presbyterian and Radin Inc., Newport Beach, California, United States

and more 53 locations

A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System

Not Applicable

Completed

Conditions: Atherosclerosis
Peripheral Vascular Disease

Interventions: Device: Dynalink®-E everolimus-eluting peripheral stent
Device: Dynalink®-E, everolimus-eluting peripheral stent

First Posted Date: 2007-05-21

Last Posted Date: 2011-03-10

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 104

Registration Number: NCT00475566

Locations: 🇦🇹
Landeskrankenhaus Klagenfurt, Klagenfurt, Austria
🇦🇹
Allgemeines Krankenhaus der Stadt Wien- AKH Wien, Wien, Austria
🇧🇪
Sint Blasius Hospital, Dendermonde, Belgium

and more 7 locations

Aortic Valve Replacement With Trifecta(TM)

Not Applicable

Completed

Conditions: Aortic Valve Stenosis
Regurgitation, Aortic Valve
Aortic Valve Insufficiency
Aortic Valve Incompetence

Interventions: Device: Trifecta Aortic Heart Valve

First Posted Date: 2007-05-21

Last Posted Date: 2019-02-19

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1022

Registration Number: NCT00475709

Locations: 🇺🇸
Sarasota Memorial Hospital/Clinical Research Center, Sarasota, Florida, United States
🇺🇸
Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States

and more 15 locations

Aortic Valve Replacement With Trifecta(TM)

Not Applicable

Completed

Conditions: Aortic Valve Stenosis
Regurgitation, Aortic Valve
Aortic Valve Incompetence
Aortic Valve Insufficiency

First Posted Date: 2007-05-21

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 203

Registration Number: NCT00475267

Locations: 🇨🇦
Montreal Heart Institute, Montreal, Quebec, Canada
🇨🇦
Hôpital Laval, Québec, Quebec, Canada
🇨🇦
University of British Columbia, St. Paul's Hospital, Vancouver, British Columbia, Canada

and more 2 locations

Efficacy and Safety Study on Agilis NxT Introducer in AF Patients

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Procedure: Left atrial catheter ablation guided by introducer using Agilis sheeth
Procedure: Left atrial catheter ablation guided by introducer using Non-steerable sheeth

First Posted Date: 2007-05-04

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 130

Registration Number: NCT00469638

Locations: 🇩🇪
Herzzenturm Leipzig, Leipzig, Germany

Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial

Not Applicable

Completed

Conditions: Cryptogenic Stroke

Interventions: Other: Standard of Care - Medical Management
Device: AMPLATZER PFO Occluder

First Posted Date: 2007-04-24

Last Posted Date: 2019-02-18

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 980

Registration Number: NCT00465270

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
UW Medicine Stroke Center, Seattle, Washington, United States
🇺🇸
Mayo Clinic, Scottsdale, Arizona, United States

and more 66 locations

RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D

Completed

Conditions: Heart Failure

First Posted Date: 2007-03-29

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 222

Registration Number: NCT00453622

Locations: 🇺🇸
Veterans' Adminstration Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy